Developmental changes of MPA exposure in children

Area of Science:

• Pharmacology
• Pediatric Nephrology
• Transplantation

Background:

• Developmental changes in Mycophenolate mofetil (MMF) drug disposition are not well understood.
• MMF is a crucial immunosuppressant in pediatric renal transplant recipients.

Purpose of the Study:

• To investigate the age-dependency of mycophenolic acid (MPA) exposure in pediatric renal transplant recipients.
• To identify factors influencing MPA trough levels in this population.

Main Methods:

• Retrospective analysis of 37 pediatric renal transplant recipients.
• Monitoring of dose-normalized MPA trough levels, along with clinical parameters like albumin, hematocrit, and eGFR.
• Univariate and multivariate analyses to assess age dependency while controlling for confounders.

Main Results:

• Age significantly correlated with dose-normalized MPA trough levels.
• Estimated glomerular filtration rate (eGFR) was a key confounder, but age dependency remained significant.
• Younger children (< 6 years) showed a greater risk for low MPA trough levels compared to adolescents.

Conclusions:

• Significant age-related differences in MPA exposure exist in pediatric renal transplant recipients.
• Pharmacokinetic monitoring of MPA is essential, particularly in younger children, to ensure therapeutic efficacy and safety.